Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CXCL9

CXCL9

Brief Information

Name:C-X-C motif chemokine 9
Target Synonym:C-X-C motif chemokine 9,Gamma-interferon-induced monokine,Monokine induced by interferon-gamma (HuMIG; MIG),Small-inducible cytokine B9,SCYB9,Crg-10,Humig,CMK,MIG,Monokine Induced By Gamma Interferon,Monokine Induced By Interferon-Gamma,Gamma-Interferon-Induced Monokine,Chemokine (C-X-C Motif) Ligand 9,Small-Inducible Cytokine B9,C-X-C Motif Chemokine 9,HuMIG
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
CX9-H51H3 Human Human CXCL9 Protein, His Tag
CX9-H51H3-structure
CX9-H51H3-sds
ACRO Quality

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
NG-641 EnAd-FAP-BiTE; EnAd-FAP-Tac; NG-641; NG-aFAP Phase 1 Clinical Akamis Bio Ltd, University Of Oxford Squamous Cell Carcinoma of Head and Neck; Neoplasms, Glandular and Epithelial; Neoplasm Metastasis Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message